Consequently, these endometrial cancers with low ERα might express higher levels of GPR30 and pFAK even with low circulating serum levels of estrogen and without the addition of exogenous estrogen, which implies that they have a potential to invade adjacent tissues. The gene discussed is ESR1; the disease is endometrial cancer.